Monday, February 16, 2026
25.9 C
Bengaluru

National Seminar on UCPMP

National Seminar on Uniform Code of Pharmaceutical Marketing Practices (UCPMP) - Karnataka Drug and Pharmaceutical Producers Association (KDPMA)

Theme: “Building Brands – Building a Future”

Friday, 16 September 2016 | Hotel Lalit Ashok, Kumara Krupa Road, Bangalore (Google Maps)


Seminar Objectives

The seminar will help companies especially Product Management Teams and Sales Teams to understand their changing roles due to UCPMP. It will also bring clarity on strategies and promotional inputs including CME’s, sampling, gifts etc. Part of deliberation will also cover monitoring and implementation of UCPMP. The eminent speakers will also share their perspective on the future of brand building in the post-UCPMP era.


Keynote Speaker

  • Shri. Sudhansh Pant, IAS – Joint Secretary, Dept. of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India

Speakers

  • Dr. Ganesh Nayak – Executive Director and CEO, Zydus Cadila Ltd.
  • Anup Soans – Editor, MedicinMan
  • Samir Rai – National Sales Manager, Meyer Organics (Sales and Marketing, in charge of 4 divisions.)
  • Dr. H. N. Ravindra – Executive Committee Member, Indian Medical Council, New Delhi

Registration

Download the registration form below and mail to the address mentioned within.

[wpfilebase tag=file id=81 tpl=thumbnail target=blank/]

 

 

 

Hot this week

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...

Topics

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...

The Uncomfortable Truth about Indian Generics: Untangling the Conundrum

India’s pharmaceutical industry occupies a unique and powerful position...

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...
spot_img

Related Articles

spot_imgspot_img